PODCAST · science
MIDialog
by Bruker Microbiology & Infection Diagnostics
A new science-driven podcast by Bruker Microbiology & Infection Diagnostics (MID)
-
5
The Horse That Helped Us See More Clearly: A MALDI-TOF Success Story
In this video podcast episode, Markita Allender, Senior Product Marketing Manager at Bruker Microbiology & Infection Diagnostics, speaks with Dr. Tessa LeCuyer, Section Chief of Microbiology at UC Davis Veterinary Medical Teaching Hospital. Together they explore how the MALDI Biotyper is advancing the identification of previously unknown bacteria and fungi, and how it has recently helped guide more effective treatment in the equine field. Not for use in clinical diagnostic procedures.Please contact your local representative for availability in your country.
-
4
The Horse That Helped Us See More Clearly: A MALDI-TOF Success Story
In this podcast, Markita Allender, Senior Product Marketing Manager at Bruker Microbiology & Infection Diagnostics, speaks with Dr. Tessa LeCuyer, Section Chief of Microbiology at UC Davis Veterinary Medical Teaching Hospital. Together they explore how the MALDI Biotyper is advancing the identification of previously unknown bacteria and fungi, and how it has recently helped guide more effective treatment in the equine field. Not for use in clinical diagnostic procedures.Please contact your local representative for availability in your country.
-
3
Emerging pathogens in healthcare: surveillance and response
In this episode, we talk to Dr. Margie Morgan and Dr. Deisy Contreras from Cedars-Sinai Medical Center, a non-profit hospital and medical research institution that serves the Los Angeles community and surrounding areas.With pioneering medical research achievements, healthcare-defining education programs, and wide-ranging community benefit activities, Cedars-Sinai is setting new standards for quality and innovation in patient care.
-
2
Emerging pathogens in healthcare: surveillance and response
In this episode, we talk to Dr. Margie Morgan and Dr. Deisy Contreras from Cedars-Sinai Medical Center, a non-profit hospital and medical research institution that serves the Los Angeles community and surrounding areas. With pioneering medical research achievements, healthcare-defining education programs, and wide-ranging community benefit activities, Cedars-Sinai is setting new standards for quality and innovation in patient care. NB: reference to MALDI-TOF means Bruker's MALDI Biotyper and as below:13:42: Biotyper refers to the IR Biotyper15:47: Biotyper Kit refers to the IR Biotyper Kit22:10: Biotyper Kit refers to the IR Biotyper Kit
-
1
Tackling the global TB challenge with next-generation diagnostics
In this podcast, Bernd Merkl, Business Unit Director Mycobacteria / TB at Bruker Microbiology and Infection Diagnostics, is joined by Professor Stefan Niemann and Dr. Inna Friesen from the National Reference Center for Mycobacteria in Germany, to discuss the evolving Tuberculosis landscape, the scale of the issue and new testing methods that are helping limit the impact on public health.
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
Loading similar podcasts...